Sedana Medical AB (7D2A) Stock Statistics & Valuation Metrics

Sedana Medical AB has a market cap or net worth of €112.77M. The enterprise value is €1.71B.

Sedana Medical AB has 99,336,960 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sedana Medical AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Sedana Medical AB is -177.57. Sedana Medical AB’s PEG ratio is 2.17.

In the last 12 months, Sedana Medical AB had revenue of 178.75M and earned -10.67M in profits. Earnings per share was -0.11.

In the last 12 months, operating cash flow was -11.77M and capital expenditures -175.00M, giving a free cash flow of -186.77M billion.

Sedana Medical AB pays an annual dividend of ―, resulting in a dividend yield of ―

Sedana Medical AB upcoming earnings date is Jul 18, 2025, TBA Not Confirmed.

Sedana Medical AB as a current ratio of 5.39, with Debt / Equity ratio of 0.62%

In the past 12 months, Sedana Medical AB has paid 726.00K in taxes.

Sedana Medical AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Sedana Medical AB has €193.96M in cash and marketable securities with kr5.92M in debt, giving a net cash position of -€188.04M billion.

Gross margin is 70.59%, with operating margin of -28.40%, and net profit margin of -5.97%.

The average price target for Sedana Medical AB is ―, which is 11.43% higher than the current price. The consensus rating is ―